A six-year clinical trial investigating diabetic patients revealed a significant association between elevated levels of both TNFR1 and TNFR2 and the risk of adverse renal outcomes in diabetic kidney disease (DKD) (52). Here, TNFRSF1B is linked to diabetic kidney disease.